EUVIMEDEUVIMED entdecken
Crossref

Matrix metalloproteinase (MMP)-10 aggravates podocyte injury in glomerulonephritis

Takuya Ishimura, Keisuke Osaki, Sayaka Sugioka, Akira Ishii, Hiroyuki Yamada iD, Naohiro Toda, Shoko Ohno, Yukiko Kato, Taiji Matsusaka, Takeshi Tokudome, Motoko Yanagita iD, Hideki Yokoi iD

Nephrology Dialysis Transplantation · 29.09.2025 · 40 (10) · 1961-1976

DOI: 10.1093/ndt/gfaf076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 05.05.2025. Verfasst von Takuya Ishimura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Podocytes, Matrix Metalloproteinase 10, Glomerulonephritis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: JSPS, AMED, Smoking Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Podocytes are integral to maintaining glomerular filtration barrier. Our previous research underscored the crucial role of podocyte guanylyl cyclase-A (GC-A) in the pathogenesis of severe albuminuria in both systemic and podocyte-specific GC-A knockout mice subjected to heminephrectomy, high salt, and aldosterone (ALDO) treatment. This study investigates the role of matrix metalloproteinase-10 (MMP-10) on glomerular injury, which was found to be highly expressed in glomeruli of ALDO-treated GC-A knockout mice.

Methods

To investigate the role of MMP-10 in glomerulonephritis, we used MMP-10 knockout mice subjected to anti-glomerular basement membrane (GBM) nephritis. Additionally, we created systemic GC-A and MMP-10 double knockout mice, as well as podocyte-specific GC-A and systemic MMP-10 double knockout mice, to analyze glomerular injury. In vitro, changes in inflammatory mRNA are examined in MMP-10-overexpressing or -knockdown mouse podocytes following stimulation of tumor necrosis factor (TNF)-α.

Results

We demonstrate that MMP-10 is highly expressed in the kidneys of patients with glomerulonephritis. MMP-10 knockout mice showed less albuminuria and lower expression of pro-inflammatory and pro-fibrotic mRNAs compared to control mice in anti-GBM nephritis. Additionally, systemic or podocyte-specific GC-A and systemic MMP-10 knockout mice exhibited improved albuminuria, preserved nephrin expression, and reduced GBM thickening compared to systemic or podocyte-specific GC-A knockout mice with ALDO treatment. MMP-10 was co-localized with podocytes and endothelial cells. In vitro studies using mouse podocytes revealed that MMP-10 overexpression upregulated inflammatory mRNA changes induced by TNF-α, whereas MMP-10 knockdown mitigated inflammation. Co-culture of mouse podocytes with human endothelial cells showed reduced inflammation following MMP-10 reduction in endothelial cells. Moreover, activated MMP-10 cleaved nephrin in vitro, contributing to podocyte injury.

Conclusion

These findings suggest that GC-A ablation leads to upregulation of MMP-10, resulting in nephrin loss, and that systemic deletion of MMP-10 ameliorates GC-A-induced podocyte injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PodocytesMatrix Metalloproteinase 10GlomerulonephritisAnimalsMiceMice, KnockoutHumansMice, Inbred C57BLMaleCells, CulturedRNA, MessengerTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

aldosteroneanti-GBM glomerulonephritisendothelial cellsnatriuretic peptides

Substanzen

Matrix Metalloproteinase 10RNA, MessengerTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Nephrology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Department of Nephrology, Kansai Electric Power Hospital, Osaka, Japan.
  • Department of Primary Care & Emergency Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Basic Medicine, Tokai University School of Medicine, Isehara, Japan.
  • Department of Pharmacology, Yokohama City University School of Medicine, Yokohama, Japan.

ORCID-Profile: Hiroyuki Yamada, Motoko Yanagita, Hideki Yokoi

Förderung

  • JSPS
  • AMED
  • Smoking Research Foundation
  • Japanese Association of Dialysis Physicians and Foundation
  • Tsuchiya Memorial Medical Foundation

Zitieren

APA

Ishimura, T., Osaki, K., Sugioka, S., Ishii, A., Yamada, H., Toda, N., Ohno, S., Kato, Y., Matsusaka, T., Tokudome, T., Yanagita, M., & Yokoi, H. (2025). Matrix metalloproteinase (MMP)-10 aggravates podocyte injury in glomerulonephritis. Nephrology Dialysis Transplantation, 40(10), 1961-1976. https://doi.org/10.1093/ndt/gfaf076

Vancouver

Ishimura T, Osaki K, Sugioka S, Ishii A, Yamada H, Toda N, et al. Matrix metalloproteinase (MMP)-10 aggravates podocyte injury in glomerulonephritis. Nephrology Dialysis Transplantation. 2025;40(10):1961-1976. doi:10.1093/ndt/gfaf076

BibTeX
@article{Ishimura2025,
  author = {Ishimura, Takuya and Osaki, Keisuke and Sugioka, Sayaka and Ishii, Akira and Yamada, Hiroyuki and Toda, Naohiro and Ohno, Shoko and Kato, Yukiko and Matsusaka, Taiji and Tokudome, Takeshi and Yanagita, Motoko and Yokoi, Hideki},
  title = {Matrix metalloproteinase (MMP)-10 aggravates podocyte injury in glomerulonephritis},
  journal = {Nephrology Dialysis Transplantation},
  year = {2025},
  volume = {40},
  number = {10},
  pages = {1961--1976},
  doi = {10.1093/ndt/gfaf076}
}
Kostenlos starten →